Session: Individual research reports Date: Wednesday, 28 th May, 2025 ...

Acute systemic infection caused the patient to develop fatal capillary leak syndrome, highlighting the unpredictability of ...

AMP-945 – discovered at the former Cancer Therapeutics Cooperative Research Centre – works by suppressing a bodily agent ...

We were surprised to find that some hospital germs, such as Pseudomonas aeruginosa, might be able to break down plastic. P ...

Mergers and acquisitions grabbed the spotlight in the biotech sector once again this week after BioMarin BMRN agreed to ...

Biotechs have faced several challenging years with slumping valuations and a competitive funding environment. However, the latest slew of ...

Shares of biotechnology company Prime Medicine, Inc. (PRME) fell 18% on Monday afternoon after the company announced a ...

Researchers have flagged some "promising" new approaches that could save lives and dramatically improve patient recovery.

Moving forward, the biotech said it will focus its resources on developing treatments for genetic liver diseases and on its partnered programs.

T he cost of prescription drugs in the U.S. has long outpaced that of peer nations, a dynamic driven by a combination of ...

The hope is that this treatment combination from Vir Biotechnology is going to be ... near-term dilution that should happen. The company burns roughly $142.5 million of cash per quarter.